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Vinyl sulfone-based ferrocenylation reagents:
applications in conjugation and bioconjugation†
Alicia Megia-Fernandez, Fernando Hernandez-Mateo and
Francisco Santoyo-Gonzalez*
The easy vinyl sulfone derivatization of ferrocene allows the preparation of some effective, versatile and
valuable ferrocenylation reagents. The applicability of such compounds in conjugation and bioconjuga-
tion of amine and/or thiol containing molecules and biomolecules through Michael-type addition under
mild conditions that preserve the biological function of the latter is described. The feasibility of the metho-
dology is demonstrated by the preparation of a variety of conjugates and bioconjugates (ferrocenyl
terminated dendrimers and ferrocene–sugar, ferrocene–cyclodextrin, ferrocene–peptide and ferrocene–
protein conjugates).
Introduction
Ferrocene (Fc) conjugation and bioconjugation1 has raised
considerable interest in many fields owing to the outstanding
properties of this prototypic metallocene compound. The well-
established and rich chemistry of this sandwich structure
allows rapid and easy access to a large number of reagents2
that have great possibilities in terms of organometallic functio-
nalization and molecular engineering. In fact, Fc can be con-
sidered nowadays to be one of the most important structural
motifs with applications in organometallic and bioorgano-
metallic chemistry,3 electrochemistry,4 asymmetric catalysis,5
materials science,1,6 preparation of functional biomaterials1
and biomedical sciences.7 The academic milieu and also
numerous industries (petroleum, plastics, textiles and metal-
lurgy) have benefited from the outstanding characteristics of
Fc. In addition to its unique structure, Fc has a panoply of
ideal properties such as low price, stability under thermal,
aqueous and aerobic conditions, together with a small size
and a relative lipophilicity. Among these properties, the favor-
able electrochemical behavior of Fc is perhaps the most valu-
able and exploited characteristic that has been widely used in
the design and construction of Fc-based systems such as redox
molecular switches and sensors. These organometallic
compounds have emerged as one of the most important
classes of materials for the direct observation of molecular
interactions and also as electron mediators, on the basis of
their electrochemical detection capabilities.8 Particularly,
ferrocenylated peptides and proteins are nowadays the most
important ferrocenylated biomolecules with great significance
in biological as well as non-biological systems. Among the
uses and applications they have found, anticancer activity and
cytotoxicity, antimalarial activity, antimycobacterial activity,
antiproliferative activity, bacterial infection detector, detection
of metal ions, drug carriers, nanobiosensors, nuclease activity,
plasmin activity, proteolytic activity, antiviral potency for
HIV-1, DNA detection, electrochemical assay of antigens,
detection of proteins, synthesis of new water-soluble electro-
chemically active probes for biomolecules, detection of single-
nucleotide polymorphisms, biochip device, DNA cleavage and
gene detection have been reported.9,10
In Fc-conjugates and bioconjugates, the Fc moiety present
plays a variety of roles: molecular scaffold, sensitive probe,
chromophore, biological marker, redox-active site, catalytic
active site and others. To attain the goal of chemical incorpo-
ration of Fc into such systems, a large variety of mono- and dis-
ubstituted ferrocenyl derivatizing agents have been developed
to perform their covalent conjugation by exploiting their reac-
tivity with different functional groups.2 The majority of ferro-
cenylation reagents are applied to the conjugation to amino
functionalities present in small organic molecules, amino
acids, peptides or proteins, which correlates well with the
strong demand for powerful analytical methods for the latter
biomolecules.9 Traditional amide coupling is the most com-
monly used strategy for attaching Fc derivatives to amino func-
tionalities either by means of Fc-carboxylic acid derivatives,
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with the assistance of coupling reagents, or by using activated
Fc-carboxylic derivatives (chlorides, activated esters, and anhy-
drides).2,7b,9,10 In addition, Schiff base chemistry and Fc-
derivatives bearing aldehyde,11 isothiocyanate2,9 or carboxyimi-
date groups12 have also been exploited to generate amino
linked Fc-conjugates.
Iodoacetamide13 and maleimide derivatized ferrocenes14
have also been successfully coupled with compounds contain-
ing thiol groups, a function that is particularly important for
its presence in cysteine residues, one of the most convenient
targets for selective modification of proteins owing to the low
natural abundance of this proteogenic amino acid. In
addition, the alkylthiolation of glycosyl thiols with ferrocene-
methanol derivatives has been described as an efficient metho-
dology for the preparation of Fc–carbohydrate conjugates.15
Other functional groups (alcohols, diols, carboxylic acids,
alkenes, dienes and imino groups) have been also used for the
construction of Fc-conjugates and bioconjugates through well-
established synthetic methodologies based on Fc reagents
bearing reactive functionalities complementary to those of
the target compounds. Furthermore, ferrocenylation has
also benefited from the advances made in some contem-
porary organic reactions and methodologies, such as the
Sonogashira and the Suzuki coupling and, particularly, click-
chemistry.16
In this context, the excellent capability of vinyl sulfones
(VS) to act as Michael acceptors toward amine and thiol
groups has been used but not fully exploited up to the present
in conjugation and bioconjugation, despite the stability and
easy accessibility of this functional group by a broad variety of
traditional synthetic methods and other contemporary reac-
tions.17 In fact, VS are productive and widely used intermedi-
ates in organic synthesis that also have remarkable biomedical
significance18 and have found applications in modern proteo-
mics, particularly in the development of labeling and immobili-
zation techniques.19 In addition, VS have also been used in
the conjugation of proteins with other biomolecules to yield
post-translational modifications.19 Attractive characteristics
offered by the methodology based on the conjugate addition
of nucleophiles to VS are the water stability of this function for
extended periods, particularly at neutral pH where they are
resistant to hydrolysis, the lack of by-products, the lack of need
for organometallic catalysts, and the stability of the formed
linkages.19 These remarkable characteristics are especially
valuable to guarantee the integrity and biological functionality
of labile biomolecules.
In some recent contributions, we have demonstrated
the feasibility of VS in bioconjugation of proteins to tackle
their fluorescent labeling, biotinylation and glycosylation, and
also in the immobilization of proteins and carbohydrates to
solid supports.20 In a proof of concept we have pointed out
the synthetic possibilities of the VS function in ferrocenylation
of proteins.20a Considering the wide potential of VS, we report
herein the validity of the vinyl sulfone-based ferrocenylation as
a general methodology for conjugation and bioconjugation of
amine and/or thiol containing molecules and biomolecules.
Results and discussion
1. Synthesis of vinyl sulfone ferrocenylation reagents (Fc-VS)
In order to prove the possibilities of the VS function in the
development of a general ferrocenylation methodology for the
preparation of Fc-conjugates and bioconjugates, the vinyl
sulfone derivatized ferrocenes (Fc-VS) {[2 (ferrocenylmethoxy)-
ethyl]sulfonyl}ethene 2 (Fc-O-VS)20a and ferrocenylmethyl-
{2-[2-(vinylsulfonyl)ethoxy]ethyl}sulfane 5 (Fc-SO-VS) were
envisioned as valuable reagents (Scheme 1).
Both compounds are easily accessible from commercially
available ferrocene methanol 1 and the rationale behind its
design is the introduction of structural variability in the con-
necting tether between the cyclopentadienyl core and the VS
group. In this way, the influence of this parameter on the elec-
trochemical properties of the ferrocenylation reagents and, as
a consequence, on the resulting ferrocenylated conjugates
could be studied. As reported, Fc-O-VS 220a is easily prepared
by reaction of 1 with a two-fold molar excess of divinyl sulfone
(DVS). By contrast, synthesis of the homologous compound 5
(Fc-SO-VS) is performed in a two-step strategy based on the
preparation of the Fc sulfur 3 as a hydroxylated intermediate.
Alkylthiolation of 1 with mercaptoethanol in acidic media of
trifluoroacetic acid allows easy formation of sulfur derivative 3
that is obtained together with the corresponding acylated com-
pound 4 as a minor product. VS derivatization of 3 was then
performed in a similar way to that implemented for accessing
compound 2, i.e. reaction with excess of DVS in basic media.
2. Synthesis of ferrocenyl-terminated dendrimers
The capabilities of the new ferrocenylation reagents for conju-
gation were first tested in the preparation of ferrocenyl-
terminated dendrimers.21 These compounds are one of the
early examples of metallodendrimers,22 a class of well-
organized macromolecules that find multifaceted applications
in the fields of molecular electronics21b and encapsulation,
and also as sensors,23 reusable catalysts24 and drug carriers to
targeted sites. On the basis of the interest of these dendrimers,
TREN (tris(2-aminoethyl) amine) 6 was chosen as a model
Scheme 1 Synthesis of vinyl sulfone ferrocenylation reagents.
Organic & Biomolecular Chemistry Paper
































































































compound to act as the core for the construction of first gener-
ation TREN-based dendrimers functionalized in the boundary
with Fc units. Michael-type addition of Fc-VS 2 or 5 to the
primary amino groups present in 6 allowed the easy and
effective coupling of both compounds. The corresponding Fc-
dendrimers 7 and 8 comprising three Fc derivatized branches
departing from a central tertiary amine unit were obtained
under mild conditions (rt and 18 h) (Scheme 2). Considering
that after the conjugation the primary amine groups are trans-
formed into secondary ones, which are also susceptible to
react with VS, the reactions were next performed under reflux
in the presence of an excess of 2 or 5 using an extended reac-
tion time (72 h) to ensure the derivatization of the less reactive
secondary amine functions. Under these conditions a com-
pound containing five Fc moieties per molecule was isolated
in high yields as the only detectable reaction product being
identified as the Fc-dendrimer 9, as deduced by its spectro-
scopic data. Attempts to fully functionalize the remaining
amino group by using longer reaction times under identical
reaction conditions were unsuccessful, a fact that can be attri-
buted to steric hindrance reasons. However, the formation of
the N-acetylated derivative 10 in almost quantitative yield was
possible. The isolation of this compound further confirms
chemically the structure of the Fc-dendrimer 9 and also
suggests the potential of the buried amino group of this multi-
valent ferrocenyl compound in coupling strategies directed
towards its covalent linkage. In particular, azide derivatization
of 9 by a classical two step one-pot procedure through its
acylation with chloroacetic anhydride followed by treatment
with sodium azide was easily performed. In this way, the azide
Fc-dendrimer 11 was obtained in high yields, a transformation
that endows click capabilities to those dendrimers to be
exploited in any click-chemistry scenario.
3. Synthesis of Fc–sugar and Fc–cyclodextrin conjugates
The evaluation of the vinyl sulfone-derivatization of Fc in bio-
conjugation was next undertaken. Amine-containing carbo-
hydrates were first chosen for this aim considering that these
are one of the most ubiquitous biomolecules. Decoration of Fc
with sugar motifs has been widely used mainly with the
purpose of conferring water solubility and biocompatibility on
the resulting ferrocenyl carbohydrate hybrids. These principles
are the basis of the panoply of applications that those com-
pounds have found. Thus, Fc–sugar conjugates are attractive
chiral auxiliaries for asymmetric synthesis owing to the mul-
tiple stereocenters present on the carbohydrate units.25 In
addition, these conjugates have also been studied for their bio-
logical applications in the development of biosensors,26 for
the electrochemical detection of carbohydrate–protein27 and
carbohydrate–carbohydrate interactions,28 in the search for
bacterial adhesion inhibitors29 and to explore their medicinal
applications as therapeutics for iron-deficiency disorders30
and as antimalarial31 and anticancer agents.32 Conjugation
between the carbohydrate and the ferrocene moieties has been
usually performed by means of the different synthetic methodo-
logies mentioned above, with a particular predominance of
O, S and N-acylation reactions, giving rise to functionalized
derivatives in which the Fc unit is mainly attached covalently
to the anomeric position but also to other positions of the
carbohydrate ring.
With this background, the 2-aminoethyl-O-glycosides
derived from the monosaccharide mannose 1233 and the
disaccharide lactose 1334 were selected as model carbohydrates
and coupled with the VS derivatized reagents 2 and 5. The
reactions were performed again under mild conditions using
pure or aqueous methanol as a solvent leading to the expected
Fc–sugar conjugates 15–18 in a simple manner and with good
to high yields (Scheme 3).
In order to expand the good results obtained in the prepa-
ration of Fc–sugars, the ferrocenylation of cyclodextrins (CD)
was next investigated taking into account both the oligo-
saccharidic nature and the importance of these cyclic com-
pounds. CDs have been widely explored for their host–guest
supramolecular encapsulation and carrier capabilities as well
as for their scaffold role in the preparation of multivalent
systems and artificial enzymes, among other applications. In
particular, Fc–CD conjugates have been already prepared with
sensing purposes in the construction of redox switches and
sensors for organic guests in aqueous solution,35,36 artificial
redox enzymes,37 mediators of enzyme-based biosensors38 and
redox-controllable amphiphilic molecules.39 With this perspec-
tive, the easily accessible mono-6-amino-6-deoxy-β-CD 1440 was
Scheme 2 Synthesis of ferrocenyl-terminated dendrimers.
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conjugated with the VS ferrocenylation reagents 2 and 5 using
aqueous DMF as a solvent to facilitate the solubilization of the
reagents and that of the resulting Fc–CD conjugates 19 and 20.
In these reactions, the protocol of the reaction was slightly
modified in order to simplify the isolation and purification
procedure by the addition of aminopropyl silica41 to exploit
the scavenger capabilities of this hybrid material to remove the
excess of the VS reagents.
4. Synthesis of Fc–peptide and Fc–protein conjugates
The ferrocenylation of peptides was next investigated. In the
current state of the art a wide variety of Fc–peptide hybrids
having different architectures have been reported. These com-
pounds are prepared with two main purposes: (i) the construc-
tion of chemical models of protein with secondary structures
highly ordered where the Fc serves as a reliable organometallic
scaffold and (ii) the preparation of platforms for the design of
chemical and biological sensors where the peptide component
serves as the recognition element whereas the Fc group acts as
the redox probe.9,10b,c,42
The intracellular tripeptide glutathione (GSH), composed of
glutamine, cysteine and glycine, is an especially important
compound owing to the role it plays in biological reactions.
Thus, this compound is involved in the reduction of the disul-
fide bonds formed within cytoplasmic proteins to cysteines, a
process in which GSH is converted into its oxidized form gluta-
thione disulfide (GSSG).43 The labelling of GSH with Fc has
been, up to the present, reported in a limited number of con-
tributions13,44 both at the C-terminal, in order to keep the sulf-
hydryl group in the reduced state,44a,b and at the sulfhydryl
group of the cysteine residue, by means of Fc-based selective
labels.13,44c–f,45 Considering the simultaneous presence in GSH
of two different heteroatomic nucleophiles (the thiol and the
primary amino group), it was thought that this tripeptide is
an ideal prototype to test the selective ferrocenylation by the
Fc–VS reagents 2 and 5. On the basis of the different nucleo-
philicity of the thiol and amino group, it is generally assumed
that VS are selective in the reactions with thiol groups relative
to amino groups, provided that the reaction is not carried
out at alkaline pH. This principle has been experimentally cor-
roborated and is the rationale behind numerous chemoselec-
tive modifications of cysteine-containing peptides by vinyl
sulfones.19
However, given the multifunctional character and complex-
ity of proteins, the preference of VS for thiol groups should be
considered with precaution, as recent findings have demon-
strated.19 When GSH 21 was reacted with 2 and 5 in the pres-
ence of NaBH4 in order to prevent its oxidation to GSSG,
almost quantitative Fc labelling of GSH was observed and iso-
lation of the corresponding structurally pure compounds 23
and 24 was performed. In these derivatives the Fc moiety is
attached exclusively to GSH through the sulfur atom of the
cysteine residue, but a participation of the primary amino
group of the glutamic residue was not observed (Scheme 4).
This finding is in accordance with the reported chemoselective
conjugation capabilities of VS towards the β-sulfhydryl group
of cysteine that were mentioned above. In spite of this result,
the aza Michael-based Fc derivatization by means of reagents
2 and 5 was next assayed in GSSG 22, taking advantage of the
masking of the thiol group through the formation of a disul-
fide bridge. In this case, the conjugation of those reagents was
also highly efficient and the N-linked Fc derivatives 25 and 26
were obtained (Scheme 4). This result proves the capabilities
of the vinyl sulfone Fc reagents in the conjugation of amine-
containing amino acids.
Having studied the conjugation of thiol and amine-
containing peptides, we next addressed the Fc bioconjugation
of proteins. The covalent attachment of Fc to proteins is a
Scheme 3 Synthesis of Fc–sugar and Fc–cyclodextrin conjugates.
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well-established post-translational modification of interest in
chemical biology owing to the very well behaved redox chem-
istry of Fc that allows multiple applications particularly in the
field of biological sensing.3,46 Among other archetypal pro-
teins, bovine serum albumin (BSA) has been the object of
ferrocenylation in different studies by means fundamentally of
a variety of N-labelling reagents that exploit the high ratio
of nucleophilic lysine residues present in this commercial
protein.45,47 As indicated, we have recently communicated the
ability of diverse proteins, including BSA, to react via the
amine groups of the Lys and His residues with VS derivatized
biological, functional and bifunctional tags including the vinyl
sulfone Fc 2.20a The reported results indicate the validity of the
VS-based labelling of proteins in mild conditions that preserve
their biological functionality, conjugations that take place
regardless of the isoelectric point, the number of potential
nucleophiles, or the presence of free Cys residues in those
biomolecules.
On the basis of the preliminary results on the ferrocenyl-
ation of BSA with 2, we now extended the bioconjugation
studies to the reaction of BSA with 5 in order to study the
plausible influence of the differences in the chemical structure
of the connecting tether. In addition, the reaction was
performed by using different Fc-VS : BSA stoichiometric ratios
to also determine the effect of this parameter on the extent of
labelling (Table 1). The reactions were performed by directly
mixing the reagents in aqueous DMSO at room temperature,
pH 8.5 and for reaction times of 24 h (Scheme 5). The Fc : BSA
ratio of the resulting conjugates 27 (Fc-O-BSA)20a and 28
(Fc-SO-BSA) was determined through the evaluation of the BSA
content using the Bradford method48 and simultaneously the
Fe content by spectrophotometry using the method reported
by Badia et al.47f
The results showed that BSA is labeled very efficiently in all
cases as demonstrated by the fact that an Fc-VS : BSA ratio as
unfavourable as 10 : 1 yielded between 7 and 9 labels per mole-
cule of BSA. In addition, it was also observed that the extent of
labelling concomitantly increased as the Fc-VS : BSA ratio
increased to reach a maximum that corresponded to less than
30 labels in the case of the Fc-BSA conjugate 27. However,
a comparative analysis showed paradoxically that the ferroceny-
lation reagent 2 is more efficient than its homologous 5 in
spite of the higher length of the connecting tether of this last
compound that could be anticipated as a factor that should
facilitate the accessibility to the reactive functional groups of
BSA. This result can be tentatively attributed to the observed
lower solubility in the reaction media of 5 with respect to that
of 2. The resulting labeled proteins were analysed by MALDI-
TOF (Fig. 1), which confirmed that the reaction takes place,
and that variations of stoichiometry exert a clear direct effect
on the number of labels coupled to BSA. Finally, a closer analy-
sis of the overall results based on the existence in BSA of a
single free Cys and 77 reactive groups demonstrates the good
reactivity of amine groups present in proteins towards vinyl
sulfones, and the existence of reactive groups that do not react,
in accordance with our previous results.
Scheme 4 Synthesis of Fc–GSH and Fc–GSSG conjugates.
Table 1 Extent of bioconjugation of BSA by Fc-VS reagents
Conjugate Fc-VS : BSA (mol) Fc/BSA (mol) (Experimental)
27 (Fc-O-BSA)20a 10 : 1 9.28
50 : 1 25.03
100 : 1 28.75
28 (Fc-SO-BSA) 10 : 1 7.02
50 : 1 13.20
100 : 1 17.00
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5. Electrochemical behaviour of ferrocene conjugates and
bioconjugates
The electrochemical properties of Fc conjugates and bioconju-
gates 7–8, 15–20 and 23–26 were studied by cyclic voltammetry
(CV), the experiments being carried out in water and/or aceto-
nitrile solutions depending on their solubility. Thus, the cyclic
voltammograms showed reversible redox couples of ferrocene/
ferrocenium (see ESI, Fig. S1–S5†). The associated values
of the half-wave potential (E1/2) for the oxidation of the Fc
appendages and the diffusion coefficient (D0) are collected in
Table 2. From these data two primary conclusions can be
extracted. First, the E1/2 value of the Fc moiety is dependent on
the nature of the tether decreasing on moving from the conju-
gates derived from 2 (conjugates 7, 15, 17 19, 23 and 25) to
those obtained in the coupling with 5 (conjugates 8, 16, 18, 20
and 24), in concordance with the higher electron-withdrawing
nature of the oxygenated tether of the former with respect to
the sulfur tether of the latter.35a Second, the E1/2 value is also
determined by the solvent in such a way that superior values
are observed when the less polar acetonitrile is used instead of
water, an effect that can be attributed to the higher solvation
of the ferrocenium ion in aqueous solution that facilitates
oxidation of the iron atom.
On the other hand, it is also remarkable that the ferrocenyl-
terminated dendrimers 7 and 8 show a unique wave in their
voltammograms. This result indicates that all the Fc moieties
present have identical half-wave oxidation potential and, there-
fore, the absence of any interaction between the different
metal centers. In addition, for the ferrocene–sugar conjugates
the carbohydrate moiety barely influences the E1/2, since no
significant differences are observed for conjugates with the
same tether and different carbohydrates (mannose and
lactose). However, in the particular case of the Fc–cyclodextrin
conjugates 19 and 20 the CV curve shows a positive shift
in the redox potential that can be attributed to the
inclusion of the ferrocene in the CD cavity and to a decom-
plexation process prior to the oxidation of the ferrocene, in
concordance with an identical behaviour observed in similar
conjugates.35a
Scheme 5 Synthesis of Fc–BSA conjugates.
Fig. 1 MALDI spectrum of Fc–BSA conjugates 27 (left) and 28 (right). (A) BSA; (B) Fc-VS : BSA 10 : 1; (C) Fc-VS : BSA 50 : 1; (D) Fc-VS : BSA 100 : 1.
Table 2 Electrochemical parameters obtained by CV from Fc-conjugates and
Fc-bioconjugates in H2O or CH3CN (0.2 mM solutions) with NaClO4 (50 mM) at
25 °C
Compound
E1/2 (V) D0 × 10
6 (cm2 s−1)
H2O CH3CN H2O CH3CN
1 0.222 0.376 11.7 27.0
2 0.253 0.411 8.6 6.6
5 0.232 0.395 6.0 7.2
7 0.421 6.0
8 0.403 9.4
15 0.262 0.416 7.5 30.3
16 0.246 0.404 3.7 7.7
17 0.262 0.410 4.5 18.3






Organic & Biomolecular Chemistry Paper
































































































The D0 values listed in Table 2 are consistent with the
degree of substitution of Fc. According to the Stokes–Einstein
equation, the D0 parameter is inversely proportional to the
hydrodynamic radius of the molecule. Therefore, a higher
molecular mass of the glycoconjugate is expected to diffuse
more slowly. In accordance with that, cyclodextrin conjugates
19 and 20 show the lowest D0 values.
Conclusions
In summary, the reported results demonstrate that the vinyl
sulfone functionalization of ferrocene derivatives allows the
implementation of a general strategy to easily perform the fer-
rocenylation of amine and thiol containing molecules and bio-
molecules through their effective Michael-type addition. The
preparation of the vinyl sulfone-based ferrocene reagents is
straightforward. The mild conditions required are a remark-
able characteristic particularly in the case of applications in
bioconjugation as they preserve the biological functionalities
of the labeled biomolecules. The developed methodology
expands the repertoire of protocols available in conjugation




Unless otherwise noted, commercially available reagents and
solvents were used as purchased without further purification.
TLCs were performed on Silica Gel 60 F254 aluminium sheets.
Reagents used for developing plates include ethanolic sulfuric
acid (10% w/v), potassium permanganate (1% w/v) and UV
light is used where applicable. Flash column chromatography
was performed on Silica Gel (230–400 mesh, ASTM). Melting
points are uncorrected. FAB mass spectra were recorded using
m-nitrobenzyl alcohol or thioglycerol as a matrix. MALDI-TOF
and MALDI mass spectra were recorded using HCCA as a
matrix. Ferrocenyl(2-methoxyethyl)sulfonyl)ethene 2 (Fc-O-VS)
was prepared following the procedure reported in the
literature.20a
Synthesis of vinyl sulfone ferrocenylation reagent 5
Synthesis of ferrocenylmethyl 2-hydroxyethylsulfide (3) and
ferrocenylmethyl 2-(trifluoroacetoxy)ethyl sulfide (4). Mercapto-
ethanol (0.16 mL, 2.34 mmol) and CF3COOH (0.49 mL,
6.13 mmol) were added to a solution of 1 (460 mg, 2.13 mmol)
in anhydrous CH2Cl2 (25 mL). After 30 min at rt, the solvent
was evaporated under reduced pressure and the resulting
crude product purified by column chromatography (EtOAc–
hexane 1 : 5 to 1 : 2). Eluted first was compound 4 (71 mg, 9%)
as a yellow syrup: νmax(film)/cm
−1: 3093, 2923, 1785, 1221,
1151 and 821; 1H-NMR (CDCl3, 400 MHz): δ 4.40 (t, 2H, J =
6.9 Hz), 4.20–4.15 (m, 9H), 3.57 (s, 2H), 2.76 (t, 2H, J = 6.9 Hz);
13C-NMR (CDCl3, 100 MHz): δ 158.3, 157.7, 157.2, 156.6, 120.3,
116.6, 112.8, 109.0, 84.8, 69.3, 69.2, 68.8, 67.1, 32.4, 29.4.
Eluted second was compound 3 (482 mg, 82%) as a yellow
solid: νmax(film)/cm
−1: 3421, 3093, 2921, 1703, 1410, 1041 and
819; 1H-NMR (CDCl3, 400 MHz): δ 4.18–4.14 (m, 9H), 3.66
(t, 2H, J = 6.0 Hz), 3.52 (s, 2H), 2.66 (t, 2H, J = 5.9 Hz), 2.22
(s, 1H); 13C-NMR (CDCl3, 100 MHz): δ 84.9, 68.8, 68.7, 68.2,





t-BuOK (20 mg, 0.18 mmol) and DVS (0.27 mL, 2.71 mmol)
were added to a solution of 3 (500 mg, 1.81 mmol) in THF
(20 mL). After 1 h at rt, the solvent was evaporated under
reduced pressure and the resulting crude product purified by
column chromatography (EtOAc–hexane 1 : 7 to 1 : 1) giving
compound 5 (600 mg, 84%) as a yellow syrup: νmax(film)/cm
−1:
2921, 1639, 1314, 1126, 820 and 754; 1H-NMR (CDCl3,
400 MHz): δ 6.78 (dd, 1H, J = 16.0, 10.0 Hz), 6.39 (d, 1H, J =
16.4 Hz), 6.07 (d, 1H, J = 10.0 Hz), 4.24–4.13 (m, 9H), 3.84 (t,
2H, J = 5.6 Hz), 3.55 (t, 2H, J = 6.5 Hz), 3.52 (s, 2H), 3.22 (t, 2H,
J = 5.6 Hz), 2.65 (t, 2H, J = 6.5 Hz); 13C-NMR (CDCl3, 75 MHz):
δ 138.0, 128.9, 85.3, 70.6, 69.2, 69.0, 68.5, 64.5, 55.1, 32.4, 31.2;
HRMS m/z (FAB+): calcd for C17H22O3S2Fe [M]
+ 394.0357,
found 394.0360.
Synthesis of ferrocenyl-terminated dendrimers
Synthesis of ferrocenyl-terminated dendrimers 7–8. Tris(2-
aminoethyl)amine (TREN, 6, 47 μL, 0.3 mmol) was added to a
solution of 220a or 5 (0.99 mmol) in i-PrOH–THF (2 : 1, 20 mL).
The reaction mixture was magnetically stirred at rt for 18 h.
Evaporation of the solvent under reduced pressure yielded a
crude product that was purified by column chromatography
giving the ferrocene–dendrimers conjugates 7–8.
Compound 7: Column chromatography (MeOH–CH2Cl2
1 : 20 to 1 : 10) gave 7 (330 mg, 96%) as an orange solid:
νmax(KBr)/cm
−1: 3420, 3096, 2922, 2852, 1638, 1463, 1312,
1124, 820 and 732; 1H-NMR (CDCl3, 300 MHz): δ 4.33 (s, 6H),
4.22 (t, 6H, J = 1.6 Hz), 4.16 (t, 6H, J = 1.6 Hz), 4.13 (s, 15H),
3.83 (t, 6H, J = 5.4 Hz), 3.34 (t, 6H, J = 6.1 Hz), 3.27 (t, 6H, J =
5.4 Hz), 3.12 (t, 6H, J = 6.2 Hz), 2.86 (brs, 3H), 2.64 (t, 6H, J =
5.0 Hz), 2.54 (t, 6H, J = 5.1 Hz); 13C-NMR (CDCl3, 75 MHz)
δ 82.5, 70.0, 69.8, 69.0, 68.8, 63.5, 54.6, 54.0, 54.0, 47.2, 42.6;
HRMS m/z (MALDI): calcd for C51H73N4O9S3Fe3 [M]
+
1149.2582, found 1149.2583.
Compound 8: Column chromatography (MeOH–CH2Cl2
1 : 10) gave 8 (291 mg, 73%) as an orange syrup: νmax(KBr)/
cm−1: 3584, 3317, 3090, 2920, 2855, 1638, 1464, 1311, 1285,
1123, 1103, 820 and 734; 1H-NMR (CDCl3, 300 MHz): δ
4.18–4.12 (m, 27 H), 3.85 (t, 6 H, J = 5.4 Hz), 3.57 (t, 6H, J =
6.6 Hz), 3.55 (s, 6H), 3.44–3.40 (m, 6H), 3.34 (t, 6H, J = 5.4 Hz),
3.18 (t, 6H, J = 5.8 Hz), 2.74–2.70 (m, 6H), 2.66 (t, 6H, J =
6.6 Hz), 2.63–2.59 (m, 6H); 13C-NMR (CDCl3, 75 MHz): δ 85.0,
70.4, 68.9, 68.8, 68.2, 64.4, 54.4, 53.9, 53.9, 47.1, 42.5, 32.3,
31.3; HRMS m/z (MALDI): calcd for C57H85N4O9S6Fe3 [M]
+
1329.2679, found 1329.2684.
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Synthesis of ferrocenyl-terminated dendrimers 9. Tris(2-
aminoethyl)amine (TREN, 6, 22 μL, 0.14 mmol) was added to a
solution of 220a (334 mg, 1.0 mmol) in t-BuOH–CH3CN (2 : 1,
20 mL). The reaction mixture was magnetically stirred under
reflux for 72 h. Evaporation of the solvent under reduced
pressure yielded a crude product that was purified by column
chromatography (CH2Cl2 to CH2Cl2–MeOH 20 : 1) giving the
ferrocene–dendrimer conjugate 9 (221 mg, 88%) as a syrup:
νmax(film)/cm
−1: 3091, 2954, 2919, 2851, 1461, 1287, 1098, 820
and 734; 1H-NMR (CDCl3, 400 MHz): δ 4.33 (s, 10H), 4.25–4.10
(m, 45H), 3.81 (t, 10H, J = 5.3 Hz), 3.30–3.10 (m, 22H), 2.87 (t,
8H, J = 6.7 Hz), 2.59 (brs, 2H), 2.44 (s, 10H); 13C-NMR (CDCl3,
100 MHz): δ 82.4, 70.0, 69.9, 69.0, 68.8, 63.5, 54.7, 52.8, 51.9,
51.8, 46.9; HRMS m/z (MALDI): calcd for C81H108N4O15S5Fe5Na
[M + Na]+ 1839.3043, found 1839.3054.
Synthesis of N-acetyl-ferrocenyl-terminated dendrimer
10. Ac2O (1 mL) was added to a cooled solution (ice-bath) of 9
(50 mg, 0.028 mmol) in pyridine (1 mL). The reaction mixture
was left to reach rt. After 3 h, MeOH (10 mL) was added. Evapo-
ration of the solvent under reduced pressure yielded a crude
product that was purified by column chromatography (MeOH–
CH2Cl2 1 : 30) to give 10 as a syrup (49 mg, 96%): νmax(film)/
cm−1: 3091, 2923, 2854, 1640 and 1126; 1H-NMR (CDCl3,
500 MHz): δ 4.33 (s, 10H), 4.24–4.11 (m, 45H), 3.81 (t, 10H, J =
5.2 Hz), 3.69 (t, 2H, J = 6.6 Hz), 3.32 (t, 2H, J = 6.9 Hz), 3.27 (m,
2H), 3.21–3.11 (m, 16H), 2.86 (t, 8H, J = 6.4 Hz), 2.49–2.37 (m,
8H), 2.04 (s, 3H); 13C-NMR (CDCl3, 125 MHz): δ 170.9, 82.1,
69.8, 69.7, 69.5, 68.8, 68.6, 68.5, 63.4, 63.3, 63.0, 54.5, 54.3,
52.8, 52.6, 51.6, 46.8, 46.7, 42.6, 40.3, 21.6; HRMS m/z
(MALDI): calcd for C83H110N4O16S5Fe5Na [M + Na]
+ 1881.3164,
found 1881.3160.
Synthesis of azido-ferrocenyl-terminated dendrimer
11. Chloroacetic anhydride (14 mg, 0.83 mmol) dissolved in
CHCl3 (2 mL) was added to a solution of 9 (100 mg,
0.055 mmol) in CHCl3 (10 mL). The reaction mixture was mag-
netically stirred at rt for 1 h. Evaporation of the solvent under
reduced pressure yielded a crude product that was dissolved in
DMF (5 mL). NaN3 (36 mg, 0.55 mmol) was then added and
the resulting solution magnetically stirred at rt for 24 h. Evapo-
ration of the solvent under reduced pressure yielded a crude
product that was purified by column chromatography (MeOH–
CHCl3 1 : 30) giving 11 (90 mg, 82%) as a syrup: νmax(film)/
cm−1: 3091, 2923, 2858, 2104, 1655, 1288, 1126, 1097, 819 and
751; 1H-NMR (CDCl3, 400 MHz): δ 4.27 (s, 10H), 4.19–4.04 (m,
45H), 3.86 (s, 2H), 3.75 (t, 10H, J = 5.0 Hz), 3.66 (t, 2H, J =
6.4 Hz), 3.28 (t, 2H, J = 6.4 Hz), 3.20 (brs, 2H), 3.12 (t, 8H, J =
5.0 Hz), 3.06 (t, 8H, J = 6.4 Hz), 2.88 (brs, 2H), 2.83–2.76 (m,
10H), 2.42–2.29 (m, 8H); 13C-NMR (CDCl3, 100 MHz): δ 167.1,
81.1, 68.8, 68.7, 68.6, 67.9, 67.6, 62.4, 62.3, 62.0, 53.5, 53.4,
52.6, 51.8, 51.6, 51.3, 50.5, 50.4, 49.3, 45.7, 45.6, 39.5. HRMS
m/z (MALDI): calcd for C83H109N7O16S5Fe5Na 1922.3181, found
1922.3179.
Synthesis of ferrocene–sugar conjugates
General procedure. The amino sugar 1233 or 1334
(0.5 mmol) dissolved in MeOH or H2O (4 mL) respectively was
added to a solution of the vinyl sulfones 220a or 5 (0.55 mmol)
in MeOH (20 mL). The reaction mixture was magnetically
stirred at rt for 18 h. After this time, evaporation of the solvent
under reduced pressure yielded a crude product that was puri-
fied by column chromatography giving the ferrocene–sugar
conjugates 15–18.
Compound 15: Column chromatography (CH3CN–H2O
10 : 1) gave 15 (250 mg, 90%) as a yellow syrup: [α]D +21.2
(c 0.5, MeOH); νmax(film)/cm
−1: 3549, 2920, 1657, 1460 and
1045; 1H-NMR (CD3OD, 400 MHz): δ 4.76 (d, 1H, J = 1.5 Hz),
4.36 (s, 2H), 4.26 (t, 2H, J = 1.8 Hz), 4.18 (t, 2H, J = 1.8 Hz),
4.15 (s, 5H), 3.86–3.79 (m, 5H), 3.75–3.66 (m, 2H), 3.60 (t, 1H,
J = 9.4 Hz), 3.54–3.50 (m, 2H), 3.36–3.32 (m, 4H), 3.11 (t, 2H,
J = 6.7 Hz), 2.83–2.76 (m, 2H); 13C-NMR (CD3OD, 75 MHz):
δ 101.8, 83.8, 74.8, 72.5, 72.0, 70.7, 70.6, 69.7, 69.5, 68.7,
67.3, 64.5, 62.9, 55.1, 54.7, 49.1, 43.2; HRMS m/z (MALDI):
calcd for C23H35NO9SFeNa [M + Na]
+ 580.1273, found
580.1274.
Compound 16: Column chromatography (CH3CN–H2O 5 : 1)
gave 16 (290 mg, 94%) as a yellow syrup: [α]D +11.2 (c 0.5,
MeOH); νmax(film)/cm
−1: 3504, 2920, 1656, 1460, 1070 and
811; 1H-NMR (CD3OD, 500 MHz): δ 4.77 (d, 1H, J = 1.1 Hz),
4.20 (t, 2H, J = 1.6 Hz), 4.14 (s, 5H), 4.12 (t, 2H, J = 1.7 Hz),
3.87–3.81 (m, 5H), 3.74–3.68 (m, 2H), 3.63–3.56 (m, 5H),
3.56–3.50 (m, 2H), 3.40 (t, 2H, J = 6.8 Hz), 3.38 (t, 2H, J =
5.1 Hz), 3.12 (t, 2H, J = 6.6 Hz), 2.86–2.81 (m, 2H), 2.68 (t, 2H,
J = 6.4 Hz); 13C-NMR (CD3OD, 100 MHz): δ 101.8, 86.6, 74.8,
72.6, 72.1, 71.4, 69.9, 69.8, 69.0, 68.7, 67.4, 65.6, 63.0,
55.1, 54.9, 49.3, 43.3, 32.9, 32.3; HRMS m/z (MALDI):
calcd for C25H39NO9S2FeNa [M + Na]
+ 640.1307, found
640.1308.
Compound 17: Column chromatography (CH3CN–H2O 5 : 1)
gave 17 (255 mg, 71%) as a yellow syrup: νmax(KBr)/cm
−1: 3407,
2924, 1653, 1291, 1121 and 619; 1H-NMR (DMSO-d6,
400 MHz): δ 4.36 (s, 2H), 4.35 (d, 1H, J = 8.7 Hz), 4.31 (d, 1H,
J = 7.7 Hz), 4.26 (s, 2H), 4.18 (s, 2H), 4.15 (s, 4H), 3.95 (m, 1H),
3.91 (dd, 1H, J = 12.1, 2.3 Hz), 3.86–3.80 (m, 4H), 3.78 (dd, 1H,
J = 11.4 and 7.5 Hz), 3.69 (dd, 2H, J = 11.3 and 4.4 Hz),
3.60–3.51 (m, 4H), 3.48 (dd, 1H, J = 9.7 and 3.2 Hz), 3.44–3.39
(m, 1H), 3.37–3.32 (m, 4H), 3.27 (d, 1H, J = 8.3 Hz), 3.11 (m,
2H), 2.82 (m, 2H); 13C-NMR (DMSO-d6, 100 MHz): δ 105.9,
105.1, 82.3, 81.4, 77.9, 77.3, 77.1, 75.6, 75.5, 73.4, 71.5, 71.1,
70.6, 70.4, 69.7, 65.2, 63.3, 62.7, 55.8, 55.2; HRMS m/z
(MALDI): calcd for C29H45NO14SFeNa [M + Na]
+ 742.1795,
found 742.1802.
Compound 18: Column chromatography (CH3CN–H2O 5 : 1)
gave 18 (308 mg, 79%) as a yellow syrup: νmax(film)/cm
−1:
3381, 2925, 1654, 1284, 1123 and 619; 1H-NMR (DMSO-d6,
400 MHz): δ 5.04 (brs, 1H), 4.22–4.10 (m, 11H), 3.79 (m, 1H),
3.74 (t, 3H, J = 5.5 Hz), 3.61 (brs, 2H), 3.55 (s, 2H), 3.53–3.39
(m, 7H), 3.35–3.20 (m, 7H), 3.03 (t, 1H, J = 7.9 Hz), 2.98 (brs,
2H), 2.75 (brs, 2H), 2.60 (t, 2H, J = 6.7 Hz); 13C-NMR (DMSO-
d6, 100 MHz): δ 103.8, 102.7, 85.0, 80.7, 75.4, 74.8, 74.5, 73.2,
73.1, 70.5, 69.7, 68.5, 68.4, 68.1, 67.6, 63.7, 60.5, 60.3, 53.2,
48.0, 41.9, 31.1, 30.4; HRMS m/z (MALDI): calcd for
C31H50NO14S2Fe [M]
+ 780.2016; found 780.2017.
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Synthesis of ferrocene–cyclodextrin conjugates
General procedure. Mono-6-amino-6-deoxy-β-CD 14 (100 mg,
0.088 mmol) was added to a solution of vinyl sulfone 220a or 5
(0.106 mmol) in DMF–H2O (1 : 1, 10 mL). The reaction mixture
was magnetically stirred at rt for 24 h. After this time, amino-
propyl silica41 (40 mg) was added and the resulting suspension
was heated at 60 °C until complete disappearance of the
excess of 220a or 5 was observed by TLC (4 h). After filtration
and washing of the filtrate with water (10 mL), evaporation of
the resulting solution under reduced pressure was followed by
lyophilization giving the corresponding ferrocene–cyclodextrin
conjugates 19–20.
Compound 19: Isolated as a yellow solid (121 mg, 94%). Mp
191–192 °C; [α]D +86.6 (c 1, water); νmax(film)/cm
−1: 3398,
2916, 1642, 1410, 1150, 1077 and 1026; 1H-NMR (DMSO-d6,
500 MHz) (selected signals): δ 4.91–4.79 (m, 7H), 4.24–4.08 (m,
11H); 13C-NMR (DMSO-d6, 100 MHz): δ 102.7, 102.6, 102.5,
82.4, 82.3, 82.2, 81.9, 81.7, 73.4, 73.2, 72.9, 72.6, 72.4, 69.7,
69.6, 68.7, 60.4, 60.3, 60.1, 55.9, 55.3, 53.4, 48.9; HRMS m/z
(MALDI): calcd for C57H89NO37SFeNa [M + Na]
+ 1490.4092,
found 1490.4076.
Compound 20: Isolated as a yellow solid (129 mg, 96%): Mp
198–199 °C; [α]D +84.7 (c 1, water), νmax(KBr)/cm
−1: 3361, 2925,
1654, 1384, 1155 and 1030; 1H-NMR (DMSO-d6, 400 MHz)
(selected signals): δ 4.87 (s, 7H), 3.04 (m, 2H), 2.82 (t, 2H, J =
6.0 Hz), 2.69 (m, 2H), 2.40 (t, 2H, J = 6.0 Hz); 13C-NMR (DMSO-
d6, 125 MHz): δ 103.0, 102.9, 102.7, 102.6, 102.3, 85.4, 84.6,
82.4, 82.3, 82.0, 81.9, 81.8, 79.4, 73.3, 73.2, 73.1, 72.8, 72.7,
72.6, 72.4, 71.6, 69.1, 68.9, 68.7, 68.6, 68.3, 68.1, 64.6, 60.3,
60.2, 60.1, 54.3, 53.9, 50.1, 42.7, 32.0, 30.2; HRMS m/z
(MALDI): calcd for C59H93NO37S2FeNa [M + Na]
+ 1550.4102,
found 1550.4109.
Synthesis of ferrocene–GSH conjugates
General procedure. Vinyl sulfones 220a or 5 (0.36 mmol) and
NaBH4 (13 mg, 0.34 mmol) were successively added to a solu-
tion of glutathione 21 GSH (100 mg, 0.33 mmol) in DMF–H2O
(1 : 1, 15 mL) under magnetic stirring. The solution was kept at
rt for 1 h. AcOH was then added to neutralize the excess of
NaBH4. Evaporation and co-evaporation with toluene of
the solvent under reduced pressure yielded a crude
product that was purified by column chromatography to give
the corresponding ferrocene–GSH conjugates 23–24.
Compound 23: Column chromatography (H2O–CH3CN 1 : 4)
gave 23 (209 mg, 100%) as an orange solid: Mp 185–186 °C;
[α]D −12.6 (c 1, water); νmax(film)/cm−1: 3420, 3094, 2924, 1651,
1542, 1397, 1315, 1118 and 668; 1H-NMR (D2O, 400 MHz):
δ 4.50 (dd, 1H, J = 8.6, 5.0 Hz), 4.40–4.15 (m, 11H), 3.85 (t, 2H,
J = 4.8 Hz), 3.72–3.66 (m, 3H), 3.42–3.31 (m, 4H), 2.95 (dd, 1H,
J = 14.1, 4.9 Hz), 2.86 (dd, 2H, J = 9.0, 5.8 Hz), 2.77 (dd, 1H, J =
14.1, 8.8 Hz), 2.45 (t, 2H, J = 7.8 Hz), 2.07 (q, 2H, J = 7.3 Hz);
13C-NMR (D2O, 75 MHz): δ 177.0, 175.8, 174.9, 172.5, 82.8,
70.9, 70.3, 69.9, 63.5, 55.1, 54.9, 44.3, 34.0, 32.4, 27.2, 24.2;
HRMS m/z (MALDI): calcd C25H35N3O9S2Fe [M]
+ 641.1142,
found 641.1164.
Compound 24: Column chromatography (H2O–CH3CN 1 : 4)
gave 24 (224 mg, 98%) as an orange syrup: [α]D −13.4 (c 1,
water); νmax(film)/cm
−1: 3382, 3083, 2922, 1643, 1607, 1544,
1405, 1313, 1113 and 618 cm−1; 1H-NMR (DMSO-d6, 400 MHz):
δ 4.50 (m, 1H), 4.18–4.09 (m, 9H), 3.74 (d, 2H, J = 4.5 Hz),
3.69–3.59 (m, 3H), 3.49 (s, 4H), 3.41 (t, 2H, J = 7.3 Hz), 3.32 (m,
2H), 2.99 (m, 2 H), 2.86 (t, 2H, J = 7.7 Hz), 2.84–2.75 (m, 2H),
2.59 (t, 2H, J = 5.1 Hz), .2.41 (t, 2H, J = 7.0 Hz), 2.04 (q, 2H, J =
6.9 Hz); 13C-NMR (D2O, 125 MHz): δ 177.0, 175.7, 175.0, 172.5,
86.4, 71.1, 70.3, 70.1, 69.5, 64.8, 55.3, 55.2, 54.3, 54.1, 44.6,
34.4, 32.8, 32.6, 32.1, 27.4, 24.7; HRMS m/z (MALDI): calcd
C27H39N3O9S3FeNa [M + Na]
+ 724.1099, found 724.1096.
Synthesis of ferrocene–GSSG conjugates
General procedure. Vinyl sulfones 220a or 5 (0.36 mmol) and
Et3N (43 μL, 0.33 mmol) were successively added to a solution
of oxidized glutathione 21 GSSG (100 mg, 0.16 mmol) in DMF–
H2O (1 : 1, 10 mL) under magnetic stirring. The solution was
kept at rt for 18 h. Aminopropyl silica41 (150 mg) was then
added and the suspension heated at 60 °C until complete dis-
appearance of 2 or 5 was detected by TLC (4 h). Filtration and
washing with water (10 mL) was followed by evaporation of the
solvent giving the corresponding ferrocene–GSSG conjugates
25–26.
Compound 25: Isolated as a yellow syrup (208 mg, 100%):
νmax(film)/cm
−1: 3273, 3089, 2919, 1734, 1646, 1605, 1544,
1526, 1373, 1271, 1119 and 819; 1H-NMR (DMSO-d6, 400 MHz)
(selected signals): δ 8.32 (t, 2H, J = 8.3 Hz), 8.24 (d, 2H, J = 8.3
Hz), 4.56 (m, 2H), 4.27–4.13 (m, 22H), 3.72 (t, 8H, J = 5.7 Hz),
2.25 (t, 4H, J = 6.0 Hz); 13C-NMR (DMSO-d6, 75 MHz): δ 172.0,
171.0, 170.2, 82.6, 69.1, 68.4, 68.2, 68.1, 62.5, 60.2, 52.9, 52.8,
51.8, 41.2, 40.1, 31.6, 27.5, 27.4; HRMS m/z (MALDI): calcd for
C50H68Fe2N6O18S4 [M]
+ 1280.210, found 1280.2166.
Compound 26: Isolated as a yellow syrup (224 mg, 100%).
Mp 180–182 °C; νmax(film)/cm
−1: 3285, 3092, 2923, 1649, 1608,
1548, 1529, 1306, 1103 and 822; 1H-NMR (CDCl3, 400 MHz)
(selected signals): δ 5.23 (s, 4H), 4.13–4.03 (m, 18H), 3.79 (m,
8H), 2.60 (m, 4H), 2.30 (m, 8H), 1.34 (m, 8H), 1.19 (m, 8H);
13C-NMR (DMSO-d6, 75 MHz): δ 85.1, 69.6, 68.4, 67.5, 63.7,
60.1, 52.9, 52.7, 31.0, 30.2; HRMS m/z (MALDI): calcd for
C54H76Fe2N6O18S6 [M + H] 1400.2262, found 1400.2234.
Cyclic voltammetry (CV) assays
CV experiments were carried out in nitrogen-purged (180 s)
solutions with an instrument interfaced to a potentiostat con-
nected to a computer running EcoChimie B.V. GPES 4.9 soft-
ware. The working electrode was a platinum ring electrode
(∅ 5 mm, effective area 0.410 ± 0.009 cm2). It was immersed in
a H2SO4 50% v/v solution for 5 min and sonicated in MilliQ
water for 10 min before each experiment. The counter elec-
trode was a glassy carbon electrode (65 mm, ∅ 2 mm), which
was immersed in a 0.1 M HNO3 solution for 5 min, carefully
polished with a basic Al2O3–water slurry and sonicated in a
H2O–MeOH–CH3CN 1 : 1 : 1 mixture at 40 °C for 10 min prior
to use. An Ag/AgCl (3 M KCl) electrode was used as a reference.
Electrochemical behaviour of each compound was studied on
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0.2 mM solutions in MilliQ water or acetonitrile with 50 mM
NaClO4 as a supporting electrolyte. Cyclic voltammograms
were obtained measuring five scans at six sweep rates varying
from 0.05 to 0.5 V s−1 with a step potential of 0.002 V. The
diffusion coefficients were calculated by fitting the anodic
peak current versus square root of the sweep rate plots to the
Randles–Sevcik equation.
Ferrocene labelling of BSA. Synthesis of conjugates 27
(Fc-BSA(O)) and 28 (Fc-BSA(SO))
The ferrocenylation of BSA with 5 (conjugated Fc-BSA(SO) (28))
was undertaken by following the reported procedure for conju-
gated Fc-BSA(SO) (27):20a To three aliquots (2 mL) of a BSA
solution (2 mg mL−1) in HEPES pH 8.5 was added 5 (0.24, 1.20
and 2.4 mg) dissolved in DMSO (0.2 mL) to get BSA : VS molar
ratios of 1 : 10, 1 : 50 and 1 : 100, respectively. The samples
were kept at rt for 24 h. After centrifugation, dialysis against
phosphate buffer (85 mM, pH 7.0) was performed. The BSA
concentration was determined by the Bradford method48 and
the Fe content by spectrophotometry.47f An aliquot of each
sample was dialyzed against distilled water prior to the MALDI
analysis.
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